PCHi 2026 Concludes | CongenPharma Drives Industry Growth with New Molecules, New Technologies, New Ingredients
Publish Time:
2026-04-13
Amidst the vibrant surge of spring, innovation thrives. From March 18 to 20, the China International Exhibition for Cosmetics, Personal and Home Care Ingredients (PCHi 2026) was successfully held in Hangzhou. CongenPharma showcased its full range of new ingredients and technologies, offering novel solutions for efficacious skincare. Over three days, our booth drew great attention and was met with resounding success.
New Ingredient Matrix Debuts | Building Industry Moats
At this exhibition, CongenPharma unveiled a series of innovative molecular-structure active ingredients, including crystal high-bloom peptides, True Vitamin C Peptide, non-allergenic bakuchiol, dual-function retinol, and a next-generation whitening agent. We have also opened an exclusive collaboration channel for new ingredients, assisting brands in creating unique components, building technological moats, and achieving long-term competitiveness.
Innovative Retention Technology | Inhibiting Efflux, Enhancing Retention
Only when active ingredients enter and stay in the skin can true efficacy be achieved.
CongenPharma’s proprietary Inactiv® locking retention technology focuses on inhibiting efflux and enhancing retention, significantly increasing intracellular effective concentration to maximize ingredient performance.
Star ingredients from this platform include:
Inactiv® PDRN: patented oil‑soluble, repair & renewal;
Inactiv® 577: melanin inhibition increased by 2.5 times, more efficient whitening;
Inactiv® Resveratrol: 4× penetration, 4.37× retention;
Series of high-efficacy peptides: covering whitening, anti‑aging, and soothing.
EMPHASES® Peptide Synthesis Platform | Green, Efficient, Cost‑Reducing
As CongenPharma’s core technology, the EMPHASES® novel liquid‑phase peptide synthesis platform was a major highlight at the exhibition. With its core advantages of green chemistry, high efficiency, and cost reduction, the platform enables large‑scale, high‑quality production of peptide ingredients. It has been granted 6 Chinese invention patents, 1 US invention patent, and 1 Japanese invention patent. Popular peptides developed on this platform, such as Acetyl Hexapeptide‑8 and conotoxin peptide, have attracted significant attention.
Successful Conclusion | Building a New Future for the Beauty Industry
Moving forward with beauty, aspiring towards aesthetics – three wonderful days have come to a successful close. The recognition from global clients is both an affirmation and a driving force, a starting point for cooperation and a continuation of our responsibility.
In the future, we will continue to adhere to the dual‑engine of green sustainability and technological innovation, deeply cultivate the beauty ingredient sector, and work with global partners to build a new future for the beauty industry.
For samples or collaboration inquiries, please feel free to contact us. We look forward to seeing you at the next PCHi!
Prev:
Relevant Information
undefined
